Assessment of functional results after percutaneous transluminal coronary angioplasty by cardiopulmonary exercise test

被引：12
作者：
Klainman, E
Fink, G
Lebzelter, J
Zafrir, N
机构：
[1] Mishmar Hayarden Cardiac & Rehabil Inst, Givatayim, Israel
[2] Rabin Med Ctr, Dept Pulm, Exercise Physiol Unit, Petah Tiqwa, Israel
[3] Rabin Med Ctr, Dept Cardiol, Exercise Physiol Unit, Petah Tiqwa, Israel
[4] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
来源：
CARDIOLOGY | 1998年 / 89卷 / 04期
关键词：
cardiopulmonary exercise test; percutaneous transluminal coronary angioplasty; functional assessment; angiography; oxygen pulse;
D O I：
10.1159/000006797
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Twenty-nine patients with documented coronary artery disease underwent cardiopulmonary exercise tests before and following a percutaneous transluminal coronary angioplasty (PTCA). The patients medication regimen and exercise protocols remained the same in both cases. Following PTCA, significant improvement (p < 0.001-0.0001) was noted in oxygen consumption (1,526.8 +/- 470.0 vs. 1,686.2 +/- 390 ml/min), oxygen pulse (12.40 +/-: 2.73 vs. 13.44 +/- 2.9 ml/beat), oxygen pulse score(7.62 +/- 1.29 vs. 8.85 +/- 1.26 points) and in the ventilatory anaerobic threshold (993.1 +/- 177.6 vs. 1,089.8 +/- 150.9 ml/min) but not (p > 0.05) in maximal heart rate (128.7 +/- 16.9 vs. 132.0 +/- 17.2 beats/min). Thus, a cardiopulmonary exercise test is an effective method to assess functional results following PTCA.
引用
收藏
页码：257 / 262
页数：6
相关论文
共 50 条
[21]   THE EFFECT OF PRAVASTATIN ON PREVENTION OF RESTENOSIS AFTER SUCCESSFUL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
ONAKA, H ;
HIROTA, Y ;
KITA, Y ;
TSUJI, R ;
ISHII, K ;
ISHIMURA, T ;
KAWAMURA, K .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1994, 58 (02) :100-106
[22]   BIOLOGICAL RISK-FACTORS FOR RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
BENCHIMOL, D ;
BONNET, J ;
BENCHIMOL, H ;
DROUILLET, F ;
DUPLAA, C ;
COUFFINHAL, T ;
DESGRANGES, C ;
BRICAUD, H .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1993, 38 (01) :7-18
[23]   ANGIOGRAPHIC-PATHOLOGICAL CORRELATIONS AFTER ELECTIVE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
NARUKO, T ;
UEDA, M ;
BECKER, AE ;
TOJO, O ;
TERAGAKI, M ;
TAKEUCHI, K ;
TAKEDA, T .
CIRCULATION, 1993, 88 (04) :1558-1568
[24]   DIRECT AND INDIRECT COST OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
FITZGERALD, ST ;
MERRILL, A ;
AVERSANO, T ;
SORKIN, A .
CARDIOLOGY, 1994, 85 (05) :298-302
[25]   INTRACORONARY GALLOPAMIL DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
RAUCH, B ;
RICHARDT, G ;
BARTH, R ;
ZIMMERMANN, R ;
TILLMANNS, H ;
SCHOMIG, A ;
KUBLER, W ;
NEUMANN, FJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 :S32-S39
[26]   THE PARADIGM OF RESTENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
PREISACK, MB ;
KARSCH, KR .
EUROPEAN HEART JOURNAL, 1993, 14 :187-192
[27]   Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty [J].
Horie, H ;
Takahashi, M ;
Izumi, M ;
Takaoka, A ;
Fujita, T ;
Sakamoto, T ;
Kito, O ;
Okamura, H ;
Kinoshita, M .
CIRCULATION, 1997, 96 (01) :166-173
[28]   CORONARY-ARTERY FISTULA AS A COMPLICATION OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
BATA, IR ;
MACDONALD, RG ;
ONEILL, BJ .
CANADIAN JOURNAL OF CARDIOLOGY, 1993, 9 (04) :331-335
[29]   Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty [J].
Manegold, C ;
Alwazzeh, M ;
Jablonowski, H ;
Adams, O ;
Medve, M ;
Seidlitz, B ;
Heidland, U ;
Häussinger, D ;
Strauer, BE ;
Heintzen, MP .
CIRCULATION, 1999, 99 (10) :1290-1294
[30]   Major adverse outcomes after percutaneous transluminal coronary angioplasty: a clinical prediction rule [J].
Fortescue, EB ;
Kahn, K ;
Bates, DW .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (01) :17-27
12345